Zomedica Corp

Insider buying fuels optimism for Zomedica Corp. – 10% jump in shares, modest price lift, and rising social‑media buzz signal a potential rebound, but negative earnings and regulatory delays call for cautious, long‑term analysis.

Insider buying fuels optimism for Zomedica—CEO’s recent stake boost confidence, aligning executive and shareholder interests while the stock rallies toward a 52‑week high.

Zomedica’s CEO buys 250k shares at $0.11, reflecting insider confidence as the company drives growth with its PulseVet, Assisi devices and new development services.